Strategic Lens

Pharma and health: New Zealand and United States

First country

Second country

In 2025, New Zealand sold USD 85.3 million of pharmaceutical products to United States and bought USD 223 million from it.

Benefits

  • BothTwo-way trade in pharmaceutical products grew 53 percent, from USD 202 million in 2019 to USD 309 million in 2025.

Sources: UN Comtrade (public preview API), annual goods trade, HS classification (retrieved 26 September 2026)

Last updated on 26 September 2026

The numbers

New Zealand's exports to United States: pharmaceutical products

USD million · 2019 to 2025, calendar years, as reported by New Zealand

2019: 66.8Low 66.8 / High 85.32025: 85.3

201966.8
202072
202181
202275.7
202366.9
202478.8
202585.3

Sources: UN Comtrade (public preview API), annual goods trade, HS classification (retrieved 26 September 2026)

Data retrieved 26 September 2026

New Zealand's imports from United States: pharmaceutical products

USD million · 2019 to 2025, calendar years, as reported by New Zealand

2019: 134.8Low 124.1 / High 223.52025: 223.5

2019134.8
2020124.1
2021171.4
2022207.3
2023168.3
2024161.3
2025223.5

Sources: UN Comtrade (public preview API), annual goods trade, HS classification (retrieved 26 September 2026)

Data retrieved 26 September 2026